Tokyo Court Dismisses Genentech’s Bid to Block Rituxan Biosimilar

May 30, 2019
The Tokyo District Court on May 29 struck down a patent infringement suit filed by Genentech over a biosimilar version of Rituxan (rituximab) by Sandoz and Kyowa Hakko Kirin, according to Chugai Pharmaceutical, which is assisting the Roche comrade in...read more